U-Blot® Research Grade Anti-Human CD123/IL3RA (KHK2823)Cat. No. WA1240Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD123/IL3RA (KHK2823)Cat. No. WA1240
U-Blot® Research Grade Anti-Human CD123/IL3RA (CSL360)Cat. No. WA1239
U-Blot® Research Grade Anti-Human CD122/IL2RB (Mik beta 1)Cat. No. WA1238
U-Blot® Research Grade Anti-Human CD121a/IL1R1 Antibody (AMG108)Cat. No. WA1237
U-Blot® Research Grade Anti-Human CD121a/IL1R1 (MEDI8968)Cat. No. WA1236
U-Blot® Research Grade Anti-Human CD120b/TNFRSF1B/TNFR2 Antibody (UC2.3.8)Cat. No. WA1235
U-Blot® Research Grade Anti-Human CD120b/TNFRSF1B/TNFR2 (HFB200301)Cat. No. WA1234
U-Blot® Research Grade Anti-Human CD120b/TNFRSF1B/TNFR2 (BI-1910)Cat. No. WA1233
U-Blot® Research Grade Anti-Human CD120b/TNFRSF1B/TNFR2 (BI-1808)Cat. No. WA1232
U-Blot® Research Grade Anti-Human CD120b/TNFRSF1B/TNFR2 (BC011)Cat. No. WA1231
U-Blot® Research Grade Anti-Human CD120a/TNFRSF1A/TNFR1 (GSK1995057)Cat. No. WA1230
U-Blot® Research Grade Anti-Human CD120a/TNFRSF1A/TNFR1 (GSK 2862277)Cat. No. WA1229